Bovilis IBR marker live - Data sheet

Bovilis IBR marker live

Description

Bovilis IBR marker is a live attenuated marker vaccine containing per dose at least 5.7 log10 TCID50 of gE- BoHV-1 strain GK/D.

Indication

Bovine herpesvirus type 1 (BoHV-1) the causative agent of infectious bovine rhinotracheitis (IBR). Bovilis IBR marker is for active immunisation of cattle to reduce the intensity and duration of the clinical signs induced by an infection with BoHV-1 and to reduce excretion of field virus.

Dosage and administration

For intranasal and intramuscular administration. The use of a nozzle is recommended for intranasal administration.

Reconstitute the vaccine immediately before use with Unisolve (2 ml per dose).

Method of administration:

• before the age of 3 months: intranasal
• from the age of 3 months onwards: intranasal or intramuscular

Vaccination schedule

• Basic vaccination:
  • Before the age of 3 months:
    Two vaccinations, each with a single dose: the first vaccination from the age of 2 weeks onwards and the second vaccination at the age of 3 - 4 months.
  • From the age of 3 months onwards:
    Single vaccination, with one dose per animal
• Revaccination:
  • Revaccinate with a single dose every 6 months.

Side effects

After vaccination a slight transient rise in temperature (1°C) can be seen. An increase of nasal discharge can be observed after intranasal vaccination.

Withdrawal period

None

Notes

The vaccine does not elicit antibodies to glycoprotein E of BoHV-1 (marker vaccine). This enables discrimination between cattle vaccinated with the product and cattle infected with BoHV-1 field virus.

Additional information

Use before expiry date printed on the pack.

Storage

Store dark at 2-8°C.

Presentation

Cardboard boxes with 1 or 10 vials, with 5, 10, 25, or 50 doses per vial.

Top of page